🇺🇸

US SEC Filing Intelligence

· daily

US Corporate Distress Financial Stress SEC Filings — October 05, 2026

The four filings reveal stark distress across US-listed companies, with two imminent delistings and one bankruptcy filing on a single day. ESS Tech faces a second NYSE delisting for failing to maintain a $15 million market cap, forcing a move to OTC markets and severely reducing liquidity. Purple Innovation received a Nasdaq non-compliance notice for failing the $15 million MVPHS threshold, with a compliance deadline that appears to contain a typo, adding uncertainty. Leslie's filed for Chapter 11 bankruptcy on September 30, 2026, securing a $90 million DIP facility to fund operations. CECO Environmental's voluntary switch from Nasdaq to the Texas Stock Exchange is the only non-distressed event, though it signals a strategic shift. No insider trading or forward-looking guidance was disclosed in any filing, limiting fundamental trend analysis. The cluster of events on September 30 and October 2, 2026, suggests macro pressures from rising rates or sector-specific headwinds are accelerating distress.

4 high priority 4 total filings
· daily

Global High-Priority Regulatory Events — October 05, 2026

This digest covers 50 filings from October 5, 2026, dominated by a wave of corporate restructurings, delistings, and M&A activity. The most critical developments include the Chapter 11 bankruptcy of Leslie's, Inc., the voluntary delisting of Dillard's, Inc. from the NYSE, and the completed mega-merger of Skyworks Solutions and Qorvo. A significant trend is the high volume of SPAC activity, with several business combinations progressing and one new IPO pricing, alongside multiple insolvency proceedings in the Indian market. Period-over-period data reveals mixed financial health, with Lincoln Bancorp showing a sharp swing to a net loss ahead of its merger, while Satiya Nutraceuticals (Marico subsidiary) demonstrates explosive revenue growth. The overall market implication is a bifurcated environment where strategic, value-creating transactions (GEO Group, Skyworks/Qorvo) coexist with financial distress and liquidity events (Leslie's, ESS Tech).

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 05, 2026

Today's filings reveal a market bifurcated between aggressive capital returns and operational distress. A significant capital allocation theme emerged, with ORIX Corp and Toyota Motor Corp collectively repurchasing over $1.5 billion in shares during September, signaling strong management confidence in their valuations. However, this contrasts sharply with severe operational disruptions at New Fortress Energy (Fast LNG unit offline) and a wave of governance red flags, including repeated failed annual meetings at Co-Diagnostics and Adial Pharmaceuticals due to Nasdaq listing delays. The SPAC sector remains active but fraught with risk, as three separate filings (Bold Eagle, Melar Acquisition, Tigerless Health) highlight liquidity pressures, redemption risks, and governance structures that heavily favor insiders. Period-over-period data from the banking sector shows mixed signals: Lincoln Bancorp's net loss widened to $13.19 million (vs. $1.2 million loss last year) due to a $15.7 million realized loss on securities, even as net interest income improved 4.2%. The most actionable intelligence centers on the $180 million Melar-Everli deal, which faces a matured $5.6 million loan, and the $43/share all-cash buyout of Bowman Consulting, offering a clear arbitrage opportunity.

17 high priority 33 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 05, 2026

The 14 filings for the S&P 500 Consumer Discretionary stream on October 5, 2026, are dominated by insider trading activity, primarily from Carvana Co. (10 filings), with notable transactions from Amazon, DoorDash, and Ross Stores. The overall sentiment is mixed, with a clear pattern of C-suite and director-level selling at Amazon and DoorDash, contrasted by a significant director purchase at Carvana, suggesting a potential divergence in management conviction. Carvana's CFO executed a large sale ($1.55M) alongside option exercises, while multiple other Carvana executives had shares withheld for taxes, a routine but notable event. Ross Stores awarded new stock to directors, a neutral capital allocation signal. No period-over-period financial comparisons, forward-looking guidance, or capital allocation changes (dividends/buybacks) were present in these filings, limiting the ability to identify broad sector trends. The key actionable insight is the insider activity dichotomy: selling at high-growth tech-enabled retailers (Amazon, DoorDash) versus a director's bullish purchase at Carvana, which warrants further investigation into each company's fundamentals.

14 high priority 14 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 05, 2026

The majority of this healthcare digest's 12 filings are routine Form 4 insider transactions, primarily routine director stock awards at UnitedHealth Group and tax-withholding exercises at Bristol Myers Squibb and Biogen, indicating no significant insider conviction signals. The most material developments are Medtronic's launch of its MiniMed diabetes-care separation exchange offer, a major strategic catalyst, and AbbVie's negative guidance revision due to a $216 million acquired IPR&D charge in Q3 2026. AbbVie's EPS guidance cut of $0.11 for Q3 and $0.11 for full-year 2026 signals near-term margin pressure from deal activity, though the underlying business outlook remains intact. No period-over-period revenue or margin trends were disclosed in these filings, limiting cross-company financial comparisons. The sector theme centers on capital deployment: AbbVie's aggressive M&A spending versus Medtronic's portfolio streamlining, with insider activity remaining neutral across the board. Investors should focus on the upcoming Medtronic exchange offer deadline and AbbVie's Q3 earnings call for further guidance clarity.

11 high priority 1 medium 12 total filings
· daily

US Earnings Financial Results SEC Filings — October 05, 2026

This session is extremely quiet with only one filing, Ennis, Inc.'s 10-Q for Q2 FY2027, which presents a mixed picture. While the company achieved modest top-line growth (3.4% YoY) and strong operating cash flow, a significant 28.6% decline in net earnings for the quarter overshadows the results. The earnings drop is almost entirely attributable to a swing in legal settlements, masking what appears to be stable underlying operations. The most notable capital allocation signal is the complete cessation of share buybacks, a stark contrast to the prior year, which may concern income-focused investors. With no other filings to compare, the key takeaway is a company with stable core margins but facing earnings volatility from non-operating items and a shift in shareholder return policy.

1 high priority 1 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 05, 2026

This digest of 15 proxy filings reveals a market sharply bifurcated between companies pursuing transformative M&A and those fighting for survival. A dominant theme is the surge in SPAC and de-SPAC activity, with Bold Eagle, Melar, and Bowman Consulting all seeking shareholder approval for business combinations or take-private deals, indicating a busy Q4 2026 for event-driven investors. Conversely, several micro-cap companies like XMax, Silexion Therapeutics, and Innovative Eyewear are in acute distress, seeking shareholder approval for massive dilutive financings and reverse stock splits to stave off Nasdaq delisting, creating significant risks for existing holders. Western Digital stands out as a relative bright spot, citing strong revenue growth and margin expansion from AI-driven demand, while Flex Ltd. navigates a complex spin-off and acquisition. Insider trading activity is notably absent from these filings, but forward-looking statements and capital allocation decisions—from stock splits at Seneca Foods to a critical advisory agreement change at Elevation Series Trust—provide actionable catalysts. The overall sentiment is mixed, with a clear divide between companies with strategic clarity and those in reactive, survival mode.

15 high priority 15 total filings
· daily

US IPO Pipeline SEC S-1 Filings — October 05, 2026

The IPO pipeline for October 5, 2026, is dominated by SPAC-related filings (New Iceland Arctic, Quantum Space, Tigerless Health, Welsbach Technology Metals) and two traditional IPOs (Lycia Therapeutics, Propanc Biopharma), alongside a bank merger S-4 (Equity Bancshares). A key theme is the high risk of value destruction for public shareholders in SPAC structures: Tigerless Health has no maximum redemption threshold and a dual-class structure giving 100% voting control to one insider, while New Iceland Arctic shows negative net tangible book value per share under redemption scenarios. Period-over-period data reveals deteriorating financials at Lincoln Bancorp (net loss swung to -$13.19M from -$1.207M YoY) and heavy reliance on dilutive debt at Propanc Biopharma. Lycia Therapeutics stands out as a pre-revenue biotech with promising Phase 1 data for its lead candidate LCA-0061, but no pricing details yet. The overall pipeline signals a cautious market with significant governance and financial risks embedded in the SPAC structures, while traditional IPOs remain early-stage and speculative.

7 high priority 7 total filings
· daily

US SEC Trading Suspension Halt Orders — October 05, 2026

This digest covers three US trading suspension events on October 5, 2026, revealing a bifurcated market: two companies face involuntary delisting due to market capitalization failures, while one voluntarily migrates to a new exchange. ESS Tech (GWH) received a second NYSE delisting notice after failing to maintain a $15 million average market cap over 30 days, with trading suspended immediately—a severe bearish signal amplified by the lack of insider buying or capital allocation actions. Purple Innovation (PRPL) received a Nasdaq non-compliance notice for the same $15 million threshold, with a 180-day cure period, but no insider activity or financial data suggests a credible turnaround. CECO Environmental (CECO) voluntarily delisted from Nasdaq to join the Texas Stock Exchange (TXSE), a neutral strategic move that preserves liquidity. No period-over-period comparisons, insider transactions, forward-looking guidance, or capital allocation data were provided in any filing, limiting quantitative trend analysis. The key takeaway: micro-cap and distressed companies face heightened delisting risk under NYSE/Nasdaq minimum market cap rules, while exchange migration offers an alternative for firms seeking lower regulatory costs.

3 high priority 3 total filings
· daily

US Executive Officer Management Changes SEC — October 05, 2026

This batch of 32 filings covering officer and director changes reveals a period of significant leadership transition across US-listed companies, with notable patterns in CFO turnover, insider retention, and strategic board appointments. Period-over-period comparisons from enriched data show mixed financial health: Insmed reiterated $1.25B-$1.40B revenue guidance for BRINSUPRI while NeoGenomics reported preliminary Q3 revenue of ~$209M with NGS growth of ~28% YoY, and Neighborhood Intelligence (formerly Bed Bath & Beyond) achieved over $50M in SG&A reductions year-to-date. Critical developments include Pinterest's appointment of an Amazon veteran as CFO, Chevron's internal CFO succession as part of a broader leadership reshuffle, and Aterian's going-concern qualification from its former auditor. Insider activity is limited but significant: Boost Run granted ~$76.4M in aggregate RSUs to three top executives, and Silver Bow Mining granted change-of-control-triggered RSUs to its CEO. Forward-looking data points to several catalysts: PMV Pharma's planned NDA submission in Q1 2027, WEBTOON's Marvel app launch on November 16, 2026, and NeoGenomics' CEO succession on January 4, 2027. Portfolio-level themes include a wave of CFO departures (Insmed, OFA Group, Bunge, Pinterest, Neighborhood Intelligence), strategic board appointments bringing semiconductor and Web3/AI expertise, and a clear pattern of retention-focused equity grants post-transaction or during turnaround phases.

32 high priority 32 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — October 05, 2026

Leslie's, Inc. filed for Chapter 11 bankruptcy on September 30, 2026, marking a critical inflection point for the company and the broader pool retail sector. The filing reveals a severe liquidity crisis, addressed through a $90 million debtor-in-possession (DIP) facility to fund operations during restructuring. The absence of period-over-period financial data in the filing underscores the urgency and opacity of the situation, with the company's future hinging on successful court-approved restructuring. This event signals potential distress among discretionary consumer goods retailers, particularly those with high debt loads and seasonal cash flow patterns. The DIP facility's terms, including covenants and milestones, will be key indicators of the company's restructuring trajectory. Investors should monitor the bankruptcy proceedings for asset sale opportunities and potential equity wipeout scenarios.

1 high priority 1 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 05, 2026

The 32 filings reveal a wave of C-suite and board-level transitions across US-listed companies, with notable clusters in the energy, technology, and healthcare sectors. Key themes include strategic CFO successions at Pinterest, Insmed, and Neighborhood Intelligence, often tied to growth or turnaround phases, and a trend of appointing directors with specialized expertise (semiconductors, public safety, Web3/AI). Forward-looking data highlights several catalysts, including NeoGenomics' preliminary Q3 revenue beat and guidance raise, PMV Pharma's Q1 2027 NDA submission, and WEBTOON's Marvel app launch. Risk flags include Aterian's going-concern qualification and auditor dismissal, and the lack of disclosure in Awaysis Capital's officer change filing. Insider activity is limited but includes significant retention-based RSU grants at Boost Run and Curaleaf, and a CEO board appointment at Lion Copper & Gold. Overall, the period-over-period data shows a mix of growth (NeoGenomics NGS +28% YoY) and operational challenges (Neighborhood Intelligence SG&A reductions), with capital allocation focused on executive retention and strategic hires.

32 high priority 32 total filings
· daily

USA Insider Trading Pulse — October 05, 2026

Today's insider trading pulse reveals a market dominated by routine compensation awards and option exercises, with a distinct cluster of director stock grants at Comstock Inc. and Honda Motor Co. However, the actionable signals come from a handful of open-market transactions. The most significant bullish signal is from VCI Global Ltd, where the CEO invested $313K of his own capital, a strong vote of confidence. Conversely, bearish signals dominate the tech sector, with the President of Garena at Sea Ltd executing a $3.8M 10b5-1 plan sell-down and multiple directors at Perion Network liquidating small positions. A notable pattern is the coordinated exercise of vested restricted stock units by the entire board of Simmons First National Corp and top executives at Kennametal Inc, which are neutral events but indicate a large block of shares entering the market. The overall sentiment is mixed, with a slight bearish tilt driven by the magnitude of insider selling in high-growth tech names versus the passive nature of most other filings.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — October 05, 2026

This digest covers 19 filings centered on US M&A and takeover activity, revealing a market dominated by large-scale strategic consolidations and SPAC maneuvers. A defining theme is the semiconductor sector's consolidation, highlighted by the Skyworks-Qorvo merger, which promises $500M+ in annual cost synergies and immediate EPS accretion, signaling a push for scale and efficiency. Concurrently, significant asset sales are reshaping balance sheets, with GEO Group's $950M facility sale to the US government and INNOVATE Corp.'s $559M divestiture of DBM Global, both aimed at debt reduction and enhanced shareholder returns. The SPAC landscape remains active but pressured, with several entities extending deadlines (Valuence, Launch Two) and one (Spark I) facing shareholder redemptions, while new SPACs like Southport Acquisition Corp. II enter the market with a $200M IPO. A notable trend is the use of litigation settlements for acquisitions, as seen with American Resources Corp. acquiring assets for $40M, and the rise of complex spin-offs, such as Corteva's plan to create Vylor Inc. Overall, the data points to a market prioritizing financial engineering, debt reduction, and strategic refocusing through M&A, with a mix of high-conviction insider moves and cautious capital allocation.

19 high priority 19 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 05, 2026

The overnight filing batch (Oct 4-5, 2026) reveals a market bifurcated between aggressive capital returns and liquidity-driven distress. Major capital returns dominate: Toyota repurchased ~$1.0B in September (10.9% of its authorized buyback), ORIX deployed ~$139B yen (55.6% of its program), and Bradesco completed a $1.8B capital raise. Meanwhile, SPACs and micro-caps face existential risks: Bold Eagle, Spark I, and Melar all face redemption/liquidation pressures, while Tigerless Health's deal structure allows closure despite massive redemptions. Healthcare shows mixed signals: Novo Nordisk's FDA delay is facility-related (not efficacy), Jasper's Kira acquisition closed with a $132M PIPE, but Rallybio's merger with Avenzo carries high dilution risk. Insider activity is sparse but notable: PicoCELA executives returned 5M shares, and Curaleaf's CEO received a $15.4M RSU grant. Operational disruptions (New Fortress Energy's FLNG outage) and governance failures (Co-Diagnostics' repeated quorum failures) add to the risk landscape. Period-over-period data is limited, but Lincoln Bancorp's H1 2026 net loss of $13.19M (vs $1.2M loss in H1 2025) highlights the impact of realized losses on bank earnings.

17 high priority 33 medium 50 total filings
· daily

Defense Manufacturing Contracts — October 04, 2026

The single contract analyzed for October 4, 2026, is a $497 million aggregate obligation, but this figure is misleading: the only contract in the stream is a $15 million firm-fixed-price delivery order from the Department of Transportation/Maritime Administration to TOTE SERVICES, LLC for a shipbuilding slot reservation. The remaining $482 million is unaccounted for in the provided data, suggesting either data truncation or a reporting error. This is a civilian, not defense, award with neutral signal strength (4/10) and low materiality (3/10), offering no bullish or bearish conviction. The key risk is that this is a one-time, 6-month revenue event with no options, providing zero recurring revenue visibility for TOTE SERVICES or the broader shipbuilding sector. Investors should treat this as noise, not a signal, and focus on larger, defense-aligned awards elsewhere.

1 total filings
· daily

DHS Homeland Security Contracts — October 04, 2026

This digest covers a single, large civilian contract from the Department of Homeland Security (DHS) to PAE Aviation and Technical Services LLC, a subsidiary of Amentum Services Inc., valued at $570.8 million. The contract supports U.S. Customs and Border Protection (CBP) aircraft maintenance under a cost-plus incentive fee structure, aligning with stable border security funding priorities. The highest-conviction signal is neutral: the award demonstrates competitive strength and a large potential revenue stream, but only $2.1 million has been outlayed, indicating significant execution and revenue recognition risk. Key watch items include the pace of outlays and any contract modifications or extensions beyond the March 2020 end date.

1 total filings
· daily

New Federal Contractors — October 04, 2026

The three contracts totaling $1.76 billion are entirely civilian-agency awards (0% defense-related), signaling a non-defense procurement focus for this period. The dominant theme is federal investment in geospatial engineering (Leidos, $694M) and border security aircraft maintenance (PAE/Amentum, $571M), with a smaller maritime infrastructure slot reservation (TOTE Services, $15M). The highest-conviction signal is the Leidos GSA award, but its expired performance period and negative outlay (-$163K) raise material execution concerns, making the PAE DHS contract the most actionable for near-term revenue visibility despite low outlay so far. Key risk: all three contracts show significant gaps between obligated and outlayed amounts, suggesting potential underperformance or delayed revenue recognition across the civilian procurement landscape.

3 total filings
· daily

Significant Contract Modifications ($10M+) — October 04, 2026

This digest covers three significant contract modifications totaling $1.76 billion, all awarded by civilian agencies with zero defense-related content, signaling a non-defense procurement focus. The dominant theme is large, legacy civilian contracts with expired performance periods and minimal outlays, raising questions about revenue recognition and contract health. Leidos' $694M GSA geospatial contract and PAE/Amentum's $571M DHS aircraft maintenance award both show negative or negligible outlays, suggesting potential underperformance or cancellation risk. The highest-conviction signal is the lack of current revenue from these awards, with the only near-term cash flow being TOTE Services' $15M one-time DOT shipbuilding slot reservation. Key risk: the aggregate $1.76 billion in obligations may not translate to actual revenue, as evidenced by negative outlays on the Leidos contract.

3 total filings
· daily

Contract Deobligations Alert — October 04, 2026

The three contracts analyzed total $1,762,021,191 in obligations, all from civilian agencies (GSA, DHS, DOT), with zero defense-related awards. The dominant theme is civilian infrastructure and services, led by a $694.2M GSA award to Leidos for geospatial engineering, a $570.8M DHS/CBP award to PAE Aviation for aircraft maintenance, and a $497.0M DOT award to TOTE Services for shipbuilding. The highest-conviction signal is the large, competitively awarded contracts to Leidos and PAE, indicating strong demand for their services, but both have expired or under-outlayed performance periods, raising questions about current revenue recognition. Key risks include the negative outlay on the Leidos contract and the minimal outlay on the PAE contract, suggesting potential underperformance or cancellation. Watch for contract modifications or new awards to clarify execution and pipeline strength.

3 total filings